Hopes for single-dose Hepatitis C drug fade
February 09, 2015 at 15:30 PM EST
Hopes for a single-dose Hepaititis C drug fade as tests of Regulus Therapeutics’ experimental treatment offer spotty results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.